Erik Harris

841 total citations
12 papers, 626 citations indexed

About

Erik Harris is a scholar working on Molecular Biology, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Erik Harris has authored 12 papers receiving a total of 626 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Oncology and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in Erik Harris's work include Protein Degradation and Inhibitors (3 papers), DNA Repair Mechanisms (2 papers) and Wnt/β-catenin signaling in development and cancer (2 papers). Erik Harris is often cited by papers focused on Protein Degradation and Inhibitors (3 papers), DNA Repair Mechanisms (2 papers) and Wnt/β-catenin signaling in development and cancer (2 papers). Erik Harris collaborates with scholars based in United States, Malaysia and Germany. Erik Harris's co-authors include Anne Monks, Curtis Hose, John Connelly, Edward A. Sausville, Robert H. Shoemaker, Todd Waldman, Susan D. Mertins, Ulrike Stein, Walter Birchmeier and David Allard and has published in prestigious journals such as Gastroenterology, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

Erik Harris

12 papers receiving 614 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Erik Harris United States	10	425	215	93	78	71	12	626
Filippa Pettersson Canada	18	654 1.5×	220 1.0×	96 1.0×	67 0.9×	90 1.3×	26	884
P Yue United States	9	521 1.2×	178 0.8×	117 1.3×	42 0.5×	75 1.1×	15	770
Vidula Sukhatme United States	8	353 0.8×	190 0.9×	123 1.3×	73 0.9×	56 0.8×	17	751
Lianshan Zhang China	18	352 0.8×	339 1.6×	80 0.9×	170 2.2×	82 1.2×	38	843
Frankis Almaguel United States	10	347 0.8×	286 1.3×	169 1.8×	73 0.9×	57 0.8×	23	757
T. Kris Eckols United States	13	334 0.8×	262 1.2×	52 0.6×	47 0.6×	75 1.1×	18	633
Prahlad V. Raninga Australia	15	533 1.3×	175 0.8×	115 1.2×	67 0.9×	78 1.1×	25	742
Nancy De Nève Belgium	17	490 1.2×	211 1.0×	216 2.3×	114 1.5×	87 1.2×	31	961

Countries citing papers authored by Erik Harris

Since Specialization

Citations

This map shows the geographic impact of Erik Harris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Harris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Harris more than expected).

Fields of papers citing papers by Erik Harris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Harris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Harris. The network helps show where Erik Harris may publish in the future.

Co-authorship network of co-authors of Erik Harris

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Harris. A scholar is included among the top collaborators of Erik Harris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Harris. Erik Harris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Dahlmann, Mathias, Anne Monks, Erik Harris, et al.. (2021). Combination of Wnt/β-Catenin Targets S100A4 and DKK1 Improves Prognosis of Human Colorectal Cancer. Cancers. 14(1). 37–37. 9 indexed citations

Touny, Lara H. El, Curtis Hose, John Connelly, et al.. (2021). ATR inhibition reverses the resistance of homologous recombination deficient MGMTlow/MMRproficient cancer cells to temozolomide. Oncotarget. 12(21). 2114–2130. 8 indexed citations

Evans, David M., Jianwen Fang, Thomas Silvers, et al.. (2019). Exposure time versus cytotoxicity for anticancer agents. Cancer Chemotherapy and Pharmacology. 84(2). 359–371. 22 indexed citations

Lu, Jiamo, Prabhakar Risbood, Larry Anderson, et al.. (2017). Characterization of potent and selective iodonium-class inhibitors of NADPH oxidases. Biochemical Pharmacology. 143. 25–38. 25 indexed citations

Polley, Eric C., Mark W. Kunkel, David M. Evans, et al.. (2016). Small Cell Lung Cancer Screen of Oncology Drugs, Investigational Agents, and Gene and microRNA Expression. JNCI Journal of the National Cancer Institute. 108(10). djw122–djw122. 106 indexed citations

Teicher, Beverly A., Eric C. Polley, Mark W. Kunkel, et al.. (2015). Sarcoma Cell Line Screen of Oncology Drugs and Investigational Agents Identifies Patterns Associated with Gene and microRNA Expression. Molecular Cancer Therapeutics. 14(11). 2452–2462. 55 indexed citations

Harris, Erik, Constance J. Glover, Joseph W. Adelsberger, et al.. (2006). A sterol mesylate activator of CEBPα signaling induces monocytic differentiation in human leukemia cells in vitro and in vivo. Cancer Research. 66. 1085–1085. 3 indexed citations

Banerjee, Sugato, et al.. (2006). Identification of specific calcitonin-like receptor residues important for calcitonin gene-related peptide high affinity binding. BMC Pharmacology. 6(1). 9–9. 19 indexed citations

Stein, Ulrike, Franziska Arlt, Wolfgang Walther, et al.. (2006). The Metastasis-Associated Gene S100A4 Is a Novel Target of β-catenin/T-cell Factor Signaling in Colon Cancer. Gastroenterology. 131(5). 1486–1500. 187 indexed citations

10.

Bradshaw, Tracey D., Charles S. Matthews, Eng‐Hui Chew, et al.. (2005). Elucidation of Thioredoxin as a Molecular Target for Antitumor Quinols. Cancer Research. 65(9). 3911–3919. 78 indexed citations

11.

Monks, Anne, Erik Harris, Curtis Hose, John Connelly, & Edward A. Sausville. (2003). Genotoxic Profiling of MCF-7 Breast Cancer Cell Line Elucidates Gene Expression Modifications Underlying Toxicity of the Anticancer Drug 2-(4-Amino-3-methylphenyl)-5-fluorobenzothiazole. Molecular Pharmacology. 63(3). 766–772. 47 indexed citations

12.

Monks, Anne, et al.. (2000). UCN-01 Enhances the In Vitro Toxicity of Clinical Agents in Human Tumor Cell Lines. Investigational New Drugs. 18(2). 95–107. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Filippa Pettersson Breakdown of academic impact, for papers by P Yue Breakdown of academic impact, for papers by Vidula Sukhatme Breakdown of academic impact, for papers by Lianshan Zhang Breakdown of academic impact, for papers by Frankis Almaguel Breakdown of academic impact, for papers by T. Kris Eckols Breakdown of academic impact, for papers by Prahlad V. Raninga Breakdown of academic impact, for papers by Nancy De Nève